Association between sputum culture results and pulmonary changes in children with cystic fibrosis

Association between sputum culture results and pulmonary changes in children with cystic fibrosis

Background and Objectives: Despite the significant improvement in the prognosis of cystic fibrosis (CF), it is still regarded as the most common life-shortening genetic disease in Caucasian populations. This disease is the most important cause of chronic lung disease and exocrine pancreatic insuffi...

Full description

Bibliographic Details
Main Authors:	Fatemeh Khani Nozari, Mohammadreza Modaresi, Bahar Allahverdi, Roohollah Shirzadi, Mahsa Fattahi
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2023-11-01
Series:	Iranian Journal of Microbiology
Subjects:	Cystic fibrosis; Children; Bhalla score; Sputum culture; Forced expiratory volume in 1st second
Online Access:	https://ijm.tums.ac.ir/index.php/ijm/article/view/4112

Similar Items

Comparative Evaluation of Clinical, Spiro/Oscillometric and Tomographic Parameters as a Global Assessment of Children with Cystic Fibrosis
by: Esra Toprak Kanık, et al.
Published: (2023-03-01)

Effect of Forced Expiratory Volume in One Second (FEV1) on the Quality of Life of Children with Cystic Fibrosis
by: Farzad Masiha, et al.
Published: (2019-12-01)

Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum
by: Samuel L. Neff, et al.
Published: (2024-04-01)

Reference percentiles for FEV<sub>1</sub> and BMI in European children and adults with cystic fibrosis
by: Boëlle Pierre-Yves, et al.
Published: (2012-09-01)

Cystic fibrosis microbiome: analysis of nasal middle meatus and sputum in different lung disease stages
by: F.G.O. Maestrali, et al.
Published: (2020-12-01)

Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
by: Ankan Bandyopadhyay, et al.
Published: (2013-01-01)

An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum
by: Alexander C. Graf, et al.
Published: (2021-08-01)

Quick and wide-range taxonomical repertoire establishment of the cystic fibrosis lung microbiota by tandem mass spectrometry on sputum samples
by: Pauline Hardouin, et al.
Published: (2022-10-01)

Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis
by: Lucie Charon, et al.
Published: (2023-11-01)

Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients
by: Maryury Brown-Jaque, et al.
Published: (2018-05-01)

Sputum from People with Cystic Fibrosis Reduces the Killing of Methicillin-Resistant <i>Staphylococcus aureus</i> by Neutrophils and Diminishes Phagosomal Production of Reactive Oxygen Species
by: Kayla M. Fantone, et al.
Published: (2023-09-01)

The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections
by: Aditi Aiyer, et al.
Published: (2022-06-01)

Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum
by: Karol Skłodowski, et al.
Published: (2023-11-01)

Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis
by: Gisela Hovold, et al.
Published: (2018-06-01)

Cystic Fibrosis Sputum Impairs the Ability of Neutrophils to Kill <i>Staphylococcus aureus</i>
by: Kayla Fantone, et al.
Published: (2021-06-01)

Variation in lung function is associated with worse clinical outcomes in cystic fibrosis
by: João Paulo Heinzmann-Filho, et al.
Published: (2015-12-01)

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
by: Graham Devereux, et al.
Published: (2015-10-01)

Modified forced expiration technique using expiratory resistance in adults with cystic fibrosis
by: Kathryn Watson, et al.
Published: (2023-11-01)

Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis
by: Maxine S. Eikani, et al.
Published: (2018-07-01)

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa
by: Sivagurunathan Sutharsan, et al.
Published: (2020-06-01)

Sputum induction: review of literature and proposal for a protocol
by: Marcos Eduardo Scheicher, et al.

Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients
by: Renate Kos, et al.
Published: (2022-12-01)

Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients
by: Abolhasan Halvani, et al.
Published: (2012-01-01)

Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations
by: Inger E. Moen, et al.
Published: (2011-11-01)

Positive Expiratory Pressure (PEP) versus Conventional Chest Physiotherapy in Pediatric Patients with Acute Exacerbation of Cystic Fibrosis
by: Masoumeh Ghasempour, et al.
Published: (2019-01-01)

Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
by: Maura D’Amato, et al.
Published: (2022-05-01)

Utilidad de los criterios de Murray para el procesamiento de esputo en pacientes con fibrosis quística. Laboratorio de Infectados de la Universidad de Antioquia (Medellín/Colombia)
by: Olga Lucía Morales-Múnera
Published: (2020-06-01)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis
by: Hanneke Eyns, et al.
Published: (2018-12-01)

Cystic fibrosis from genotype to phenotype: review article
by: Mohammad Sadra Modaresi, et al.
Published: (2020-10-01)

The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis
by: T. Trojan, et al.
Published: (2022-05-01)

First Cystic Fibrosis Patient Registry Annual Data Report - Cystic Fibrosis Foundation of Iran
by: Asghar Aghamohammadi, et al.
Published: (2019-02-01)

Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis
by: Paul Breen, et al.
Published: (2022-06-01)

Psychometric properties of the persian version of cystic fibrosis questionnaire: Revised in children with cystic fibrosis
by: Naser Havaei, et al.
Published: (2023-01-01)

Cystic fibrosis : everything you need to know /
by: 192669 Kepron, Wayne
Published: (2003)

Performance of Molecular Approaches for Aspergillus Detection and Azole Resistance Surveillance in Cystic Fibrosis
by: Hélène Guegan, et al.
Published: (2018-03-01)

Apparent Yield Stress of Sputum as a Relevant Biomarker in Cystic Fibrosis
by: Rosy Ghanem, et al.
Published: (2021-11-01)

The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on <i>Achromobacter xylosoxidans</i> in a Cystic Fibrosis Sputum/Lung Cell Model
by: Aditi Aiyer, et al.
Published: (2022-11-01)

An optimized protocol for assessment of sputum macrorheology in health and muco-obstructive lung disease
by: Mirjam Völler, et al.
Published: (2022-08-01)

The oral cavity as a site for developing a heterogeneous bacterial population in patients with cystic fibrosis
by: Olga V. Kondratenko, et al.
Published: (2022-12-01)